The cause of irritable bowel syndrome (IBS) is not understood, but alterations in the gut microbiome have been observed and hypothesized to be a leading cause.
Current treatment options for IBS focus largely on the management of symptoms but fail to address the underlying issues related to the microbiome.
At Viome Life Sciences, we have developed a personalized nutrition program whose goal is to reduce gastrointestinal symptoms, such as abdominal pain, cramping, bloating, diarrhea, and constipation.
The primary objective of this clinical trial is to test if nutrition recommendations and/or supplements can help improve these gastrointestinal symptoms